{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:51:32Z","timestamp":1791820292150,"version":"4.3.4"},"reference-count":168,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009978","name":"Ernest Oppenheimer Memorial Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009978","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Neville Isdell"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Despite decades of intensive research and substantial clinical gains, malaria remains a major global health challenge exacerbated by the continued emergence of drug-resistant strains of the causative agent,\n                    <jats:italic>Plasmodium<\/jats:italic>\n                    parasites. Encouragingly, recent advances in functional genomics, chemical biology and computational science are reshaping antimalarial drug discovery. In this review, we examine the discovery and development of next-generation antimalarials, including advances in phenotypic and target-based screening, omics-enabled target discovery and emerging therapeutic modalities such as long-acting agents, targeted covalent inhibitors and host-directed therapies. We further evaluate the opportunities and limitations of drug repurposing and discuss how artificial intelligence and data-driven approaches are reshaping target identification, compound optimisation and clinical development. Finally, we argue that future success will depend not only on scientific innovation but also on interdisciplinary collaboration, equitable partnerships, open science and the development of accessible therapies tailored to malaria-endemic populations.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00515-4","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:35:27Z","timestamp":1788309327000},"page":"3883-3897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["New thinking for the next generation of antimalarials"],"prefix":"10.1038","volume":"18","author":[{"given":"Hannah","family":"Asiki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Hlozek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6145-9956","authenticated-orcid":false,"given":"Kathryn J","family":"Wicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6273-5596","authenticated-orcid":false,"given":"John G","family":"Woodland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Chibale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"515_CR2","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.1021\/acsinfecdis.4c00700","volume":"10","author":"A Adam","year":"2024","unstructured":"Adam A, Besson D, Bryant R, Rees S, Willis PA, Burrows JN, Hooft van Huisjduijnen R, Laleu B, Norton L, Canan S et al (2024) Global health priority box\u2500proactive pandemic preparedness. ACS Infect Dis 10:4030\u20134039","journal-title":"ACS Infect Dis"},{"key":"515_CR3","unstructured":"Adams KA, K, Fromer J, Coley CW (2025) ShEPhERD: diffusing shape, electrostatics, and pharmacophores for bioisosteric drug design. Preprint at arXiv:2411.04130"},{"key":"515_CR4","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.ymthe.2022.04.001","volume":"30","author":"M Aleshnick","year":"2022","unstructured":"Aleshnick M, Florez-Cuadros M, Martinson T, Wilder BK (2022) Monoclonal antibodies for malaria prevention. Mol Ther 30:1810\u20131821","journal-title":"Mol Ther"},{"key":"515_CR5","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/cpt.3008","volume":"114","author":"A Aliper","year":"2023","unstructured":"Aliper A, Kudrin R, Polykovskiy D, Kamya P, Tutubalina E, Chen S, Ren F, Zhavoronkov A (2023) Prediction of clinical trials outcomes based on target choice and clinical trial design with multi-modal artificial intelligence. Clin Pharm Ther 114:972\u2013980","journal-title":"Clin Pharm Ther"},{"key":"515_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.ijpara.2012.02.004","volume":"42","author":"F Angrisano","year":"2012","unstructured":"Angrisano F, Tan YH, Sturm A, McFadden GI, Baum J (2012) Malaria parasite colonisation of the mosquito midgut\u2014placing the Plasmodium ookinete centre stage. Int J Parasitol 42:519\u2013527","journal-title":"Int J Parasitol"},{"key":"515_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-316","volume":"11","author":"MP Anthony","year":"2012","unstructured":"Anthony MP, Burrows JN, Duparc S, Moehrle JJ, Wells TN (2012) The global pipeline of new medicines for the control and elimination of malaria. Malar J 11:316","journal-title":"Malar J"},{"key":"515_CR8","doi-asserted-by":"publisher","first-page":"eaat9446","DOI":"10.1126\/science.aat9446","volume":"362","author":"Y Antonova-Koch","year":"2018","unstructured":"Antonova-Koch Y, Meister S, Abraham M, Luth MR, Ottilie S, Lukens AK, Sakata-Kato T, Vanaerschot M, Owen E, Jado JC et al (2018) Open-source discovery of chemical leads for next-generation chemoprotective antimalarials. Science 362:eaat9446","journal-title":"Science"},{"key":"515_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abo7219","volume":"14","author":"LB Arendse","year":"2022","unstructured":"Arendse LB, Murithi JM, Qahash T, Pasaje CFA, Godoy LC, Dey S, Gibhard L, Ghidelli-Disse S, Drewes G, Bantscheff M et al (2022) The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages. Sci Transl Med 14:eabo7219","journal-title":"Sci Transl Med"},{"key":"515_CR10","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1021\/acsinfecdis.0c00724","volume":"7","author":"LB Arendse","year":"2021","unstructured":"Arendse LB, Wyllie S, Chibale K, Gilbert IH (2021) Plasmodium kinases as potential drug targets for malaria: challenges and opportunities. ACS Infect Dis 7:518\u2013534","journal-title":"ACS Infect Dis"},{"key":"515_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12553-023-00738-2","volume":"13","author":"S Askin","year":"2023","unstructured":"Askin S, Burkhalter D, Calado G, El Dakrouni S (2023) Artificial Intelligence Applied to clinical trials: opportunities and challenges. Health Technol 13:203\u2013213","journal-title":"Health Technol"},{"key":"515_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00572-x","volume":"8","author":"DA Baker","year":"2017","unstructured":"Baker DA, Stewart LB, Large JM, Bowyer PW, Ansell KH, Jimenez-Diaz MB, El Bakkouri M, Birchall K, Dechering KJ, Bouloc NS et al (2017) A potent series targeting the malarial cGMP-dependent protein kinase clears infection and blocks transmission. Nat Commun 8:430","journal-title":"Nat Commun"},{"key":"515_CR13","doi-asserted-by":"publisher","first-page":"21847","DOI":"10.1074\/jbc.M501100200","volume":"280","author":"J Baldwin","year":"2005","unstructured":"Baldwin J, Michnoff CH, Malmquist NA, White J, Roth MG, Rathod PK, Phillips MA (2005) High-throughput screening for potent and selective inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase. J Biol Chem 280:21847\u201321853","journal-title":"J Biol Chem"},{"key":"515_CR14","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.clpt.2006.08.016","volume":"80","author":"KI Barnes","year":"2006","unstructured":"Barnes KI, Little F, Smith PJ, Evans A, Watkins WM, White NJ (2006) Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications. Clin Pharm Ther 80:582\u2013596","journal-title":"Clin Pharm Ther"},{"key":"515_CR15","first-page":"50","volume":"4","author":"JT Beck","year":"2020","unstructured":"Beck JT, Rammage M, Jackson GP, Preininger AM, Dankwa-Mullan I, Roebuck MC, Torres A, Holtzen H, Coverdill SE, Williamson MP et al (2020) Artificial intelligence tool for optimizing eligibility screening for clinical trials in a large community cancer center. JCO Clin Cancer Inf 4:50\u201359","journal-title":"JCO Clin Cancer Inf"},{"key":"515_CR16","doi-asserted-by":"publisher","first-page":"6260","DOI":"10.1128\/AAC.03338-14","volume":"58","author":"D Begolo","year":"2014","unstructured":"Begolo D, Erben E, Clayton C (2014) Drug target identification using a trypanosome overexpression library. Antimicrob Agents Chemother 58:6260\u20136264","journal-title":"Antimicrob Agents Chemother"},{"key":"515_CR17","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1038\/s41564-022-01249-y","volume":"7","author":"HJ Benns","year":"2022","unstructured":"Benns HJ, Storch M, Falco JA, Fisher FR, Tamaki F, Alves E, Wincott CJ, Milne R, Wiedemar N, Craven G et al (2022) CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery. Nat Microbiol 7:1891\u20131905","journal-title":"Nat Microbiol"},{"key":"515_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2026.102655","volume":"91","author":"LM Birkholtz","year":"2026","unstructured":"Birkholtz LM, Olivier T, Welcome T, Strauss E (2026) Targeted protein degradation as a novel therapeutic strategy against infectious diseases. Curr Opin Chem Biol 91:102655","journal-title":"Curr Opin Chem Biol"},{"key":"515_CR19","doi-asserted-by":"publisher","first-page":"34084","DOI":"10.1021\/acsomega.3c05138","volume":"8","author":"JVB Borba","year":"2023","unstructured":"Borba JVB, de Azevedo BR, Ferreira LA, Rimoldi A, Salazar Alvarez LC, Calit J, Bargieri DY, Costa FTM, Andrade CH (2023) Transcriptomics-guided in silico drug repurposing: identifying new candidates with dual-stage antiplasmodial activity. ACS Omega 8:34084\u201334090","journal-title":"ACS Omega"},{"key":"515_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13321-021-00487-2","volume":"13","author":"N Bosc","year":"2021","unstructured":"Bosc N, Felix E, Arcila R, Mendez D, Saunders MR, Green DVS, Ochoada J, Shelat AA, Martin EJ, Iyer P et al (2021) MAIP: a web service for predicting blood-stage malaria inhibitors. J Cheminform 13:13","journal-title":"J Cheminform"},{"key":"515_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/CMR.00051-10","volume":"24","author":"T Bousema","year":"2011","unstructured":"Bousema T, Drakeley C (2011) Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev 24:377\u2013410","journal-title":"Clin Microbiol Rev"},{"key":"515_CR22","doi-asserted-by":"publisher","unstructured":"Bower-Lepts C, Rawat M, Keith WC, Girling G, Luth MR, Carolino K, Boroviak K, Coyle R, Schwach F, Smidt C et al (2024) A novel chemogenomic screening platform for scalable antimalarial drug target identification. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.08.27.609875","DOI":"10.1101\/2024.08.27.609875"},{"key":"515_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62014-3","volume":"16","author":"NMB Brancucci","year":"2025","unstructured":"Brancucci NMB, Gumpp C, van Gemert G-J, Yu X, Passecker A, Nardella F, Thommen BT, Chambon M, Turcatti G, Halby L et al (2025) An all-in-one pipeline for the in vitro discovery and in vivo testing of Plasmodium falciparum malaria transmission blocking drugs. Nat Commun 16:6884","journal-title":"Nat Commun"},{"key":"515_CR24","doi-asserted-by":"publisher","first-page":"e1014021","DOI":"10.1371\/journal.pcbi.1014021","volume":"22","author":"L Braunack-Mayer","year":"2026","unstructured":"Braunack-Mayer L, Malinga J, Nekkab N, Kelly SL, Mohrle JJ, Penny MA (2026) Combining seasonal malaria chemoprevention with novel therapeutics for malaria prevention: a mathematical modelling study. PLoS Comput Biol 22:e1014021","journal-title":"PLoS Comput Biol"},{"key":"515_CR25","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.1039\/D5MD00335K","volume":"16","author":"SB Brettell","year":"2025","unstructured":"Brettell SB, Cann G, Begen A, Sharma S, Mahindra A, Carruthers LV, Milligan G, Clarke DJ, Tobin AB, Jamieson AG (2025) Lysine targeting covalent inhibitors of malarial kinase PfCLK3. RSC Med Chem 16:3530\u20133540","journal-title":"RSC Med Chem"},{"key":"515_CR26","doi-asserted-by":"publisher","first-page":"18895","DOI":"10.1021\/acs.jmedchem.4c01300","volume":"67","author":"SB Brettell","year":"2024","unstructured":"Brettell SB, Janha O, Begen A, Cann G, Sharma S, Olaniyan N, Yelland T, Hole AJ, Alam B, Mayville E et al (2024) Targeting PfCLK3 with covalent inhibitors: a novel strategy for malaria treatment. J Med Chem 67:18895\u201318910","journal-title":"J Med Chem"},{"key":"515_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1675-x","volume":"16","author":"JN Burrows","year":"2017","unstructured":"Burrows JN, Duparc S, Gutteridge WE, Hooft van Huijsduijnen R, Kaszubska W, Macintyre F, Mazzuri S, M\u00f6hrle JJ, Wells TNC (2017) New developments in anti-malarial target candidate and product profiles. Malar J 16:26","journal-title":"Malar J"},{"key":"515_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s42003-021-02210-1","volume":"4","author":"KA Button-Simons","year":"2021","unstructured":"Button-Simons KA, Kumar S, Carmago N, Haile MT, Jett C, Checkley LA, Kennedy SY, Pinapati RS, Shoue DA, McDew-White M et al (2021) The power and promise of genetic mapping from Plasmodium falciparum crosses utilizing human liver-chimeric mice. Commun Biol 4:734","journal-title":"Commun Biol"},{"key":"515_CR29","doi-asserted-by":"publisher","first-page":"e01465","DOI":"10.1128\/aac.01465-22","volume":"67","author":"J Calit","year":"2023","unstructured":"Calit J, Ara\u00fajo Jessica E, Deng B, Miura K, Gait\u00e1n Xiomara A, Ara\u00fajo Maisa da S, Medeiros Jansen F, Long Carole A, Simeonov A, Eastman Richard T et al (2023) Novel transmission-blocking antimalarials identified by high-throughput screening of Plasmodium berghei Ookluc. Antimicrob Agents Chemother 67:e01465\u201301422","journal-title":"Antimicrob Agents Chemother"},{"key":"515_CR30","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.mib.2020.06.004","volume":"57","author":"K Carolino","year":"2020","unstructured":"Carolino K, Winzeler EA (2020) The antimalarial resistome \u2013 finding new drug targets and their modes of action. Curr Opin Microbiol 57:49\u201355","journal-title":"Curr Opin Microbiol"},{"key":"515_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ijpddr.2022.11.001","volume":"20","author":"MP Challis","year":"2022","unstructured":"Challis MP, Devine SM, Creek DJ (2022) Current and emerging target identification methods for novel antimalarials. Int J Parasitol Drugs Drug Resist 20:135\u2013144","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"515_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41573-020-00117-w","volume":"20","author":"SN Chandrasekaran","year":"2021","unstructured":"Chandrasekaran SN, Ceulemans H, Boyd JD, Carpenter AE (2021) Image-based profiling for drug discovery: due for a machine-learning upgrade? Nat Rev Drug Discov 20:145\u2013159","journal-title":"Nat Rev Drug Discov"},{"key":"515_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1525\/cmr.2013.55.4.83","volume":"55","author":"H Chesbrough","year":"2013","unstructured":"Chesbrough H, Chen EL (2013) Recovering abandoned compounds through expanded external IP licensing. Calif Manag Rev 55:83\u2013101","journal-title":"Calif Manag Rev"},{"key":"515_CR34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210724","volume":"218","author":"HD Chien","year":"2021","unstructured":"Chien HD, Pantaleo A, Kesely KR, Noomuna P, Putt KS, Tuan TA, Low PS, Turrini FM (2021) Imatinib augments standard malaria combination therapy without added toxicity. J Exp Med 218:e20210724","journal-title":"J Exp Med"},{"key":"515_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-72427-7","volume":"14","author":"S Choudhuri","year":"2024","unstructured":"Choudhuri S, Ghosh B (2024) Computational approach for decoding malaria drug targets from single-cell transcriptomics and finding potential drug molecule. Sci Rep 14:24064","journal-title":"Sci Rep"},{"key":"515_CR1","unstructured":"ClinicalTrials.gov. Safety and PK of MMV371 LAI in healthy adults and adolescents in Rwanda. https:\/\/clinicaltrials.gov\/study\/NCT07548021"},{"key":"515_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0673-3","volume":"11","author":"AN Cowell","year":"2019","unstructured":"Cowell AN, Winzeler EA (2019) Advances in omics-based methods to identify novel targets for malaria and other parasitic protozoan infections. Genome Med 11:63","journal-title":"Genome Med"},{"key":"515_CR37","doi-asserted-by":"publisher","first-page":"e0149996","DOI":"10.1371\/journal.pone.0149996","volume":"11","author":"GJ Crowther","year":"2016","unstructured":"Crowther GJ, Hillesland HK, Keyloun KR, Reid MC, Lafuente-Monasterio MJ, Ghidelli-Disse S, Leonard SE, He P, Jones JC, Krahn MM et al (2016) Biochemical screening of five protein kinases from Plasmodium falciparum against 14,000 cell-active compounds. PLoS ONE 11:e0149996","journal-title":"PLoS ONE"},{"key":"515_CR38","unstructured":"Crutcher JM, Hoffman SL (1996) Malaria. In: Baron S (ed) Medical microbiology. University of Texas Medical Branch, Galveston"},{"key":"515_CR39","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1093\/jac\/dkv493","volume":"71","author":"S D\u2019Alessandro","year":"2016","unstructured":"D\u2019Alessandro S, Camarda G, Corbett Y, Siciliano G, Parapini S, Cevenini L, Michelini E, Roda A, Leroy D, Taramelli D et al (2016) A chemical susceptibility profile of the Plasmodium falciparum transmission stages by complementary cell-based gametocyte assays. J Antimicrob Chemother 71:1148\u20131158","journal-title":"J Antimicrob Chemother"},{"key":"515_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60221-0","volume":"10","author":"ACC de Sousa","year":"2020","unstructured":"de Sousa ACC, Combrinck JM, Maepa K, Egan TJ (2020) Virtual screening as a tool to discover new \u03b2-haematin inhibitors with activity against malaria parasites. Sci Rep 10:3374","journal-title":"Sci Rep"},{"key":"515_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05777-2","volume":"9","author":"MJ Delves","year":"2018","unstructured":"Delves MJ, Miguel-Blanco C, Matthews H, Molina I, Ruecker A, Yahiya S, Straschil U, Abraham M, Le\u00f3n ML, Fischer OJ et al (2018) A high throughput screen for next-generation leads targeting malaria parasite transmission. Nat Commun 9:3805","journal-title":"Nat Commun"},{"key":"515_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/bdr2.2012","volume":"114","author":"C Demarta-Gatsi","year":"2022","unstructured":"Demarta-Gatsi C, Donini C, Duffy J, Sadler C, Stewart J, Barber JA, Tornesi B (2022) Malarial PI4K inhibitor induced diaphragmatic hernias in rat: potential link with mammalian kinase inhibition. Birth Defects Res 114:487\u2013498","journal-title":"Birth Defects Res"},{"key":"515_CR43","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s40265-023-01839-y","volume":"83","author":"S Dhillon","year":"2023","unstructured":"Dhillon S (2023) Adagrasib: first approval. Drugs 83:275\u2013285","journal-title":"Drugs"},{"key":"515_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09894-4","volume":"10","author":"AD Douglas","year":"2019","unstructured":"Douglas AD, Baldeviano GC, Jin J, Miura K, Diouf A, Zenonos ZA, Ventocilla JA, Silk SE, Marshall JM, Alanine DGW et al (2019) A defined mechanistic correlate of protection against Plasmodium falciparum malaria in non-human primates. Nat Commun 10:1953","journal-title":"Nat Commun"},{"key":"515_CR45","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","volume":"37","author":"M Duffey","year":"2021","unstructured":"Duffey M, Blasco B, Burrows JN, Wells TNC, Fidock DA, Leroy D (2021) Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials. Trends Parasitol 37:709\u2013721","journal-title":"Trends Parasitol"},{"key":"515_CR46","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41596-020-0310-z","volume":"15","author":"JM Dziekan","year":"2020","unstructured":"Dziekan JM, Wirjanata G, Dai L, Go KD, Yu H, Lim YT, Chen L, Wang LC, Puspita B, Prabhu N et al (2020) Cellular thermal shift assay for the identification of drug\u2013target interactions in the Plasmodium falciparum proteome. Nat Protoc 15:1881\u20131921","journal-title":"Nat Protoc"},{"key":"515_CR47","doi-asserted-by":"publisher","first-page":"eaau3174","DOI":"10.1126\/scitranslmed.aau3174","volume":"11","author":"JM Dziekan","year":"2019","unstructured":"Dziekan JM, Yu H, Chen D, Dai L, Wirjanata G, Larsson A, Prabhu N, Sobota RM, Bozdech Z, Nordlund P (2019) Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay. Sci Transl Med 11:eaau3174","journal-title":"Sci Transl Med"},{"key":"515_CR48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.69808","volume":"10","author":"ER Ebel","year":"2021","unstructured":"Ebel ER, Kuypers FA, Lin C, Petrov DA, Egan ES (2021) Common host variation drives malaria parasite fitness in healthy human red cells. eLife 10:e69808","journal-title":"eLife"},{"key":"515_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-05128-1","volume":"23","author":"M El Gaaloul","year":"2024","unstructured":"El Gaaloul M, Tchouatieu AM, Kayentao K, Campo B, Buffet B, Ramachandruni H, Ndiaye JL, Wells TNC, Audibert C, Achan J et al (2024) Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile. Malar J 23:315","journal-title":"Malar J"},{"key":"515_CR50","doi-asserted-by":"publisher","first-page":"100939","DOI":"10.1016\/j.lana.2024.100939","volume":"41","author":"JL Espinoza","year":"2025","unstructured":"Espinoza JL (2025) Candidate drug repurposing for malaria: perspectives for optimising clinical trials. Lancet Region Health Am 41:100939","journal-title":"Lancet Region Health Am"},{"key":"515_CR51","doi-asserted-by":"publisher","first-page":"23889","DOI":"10.1021\/acsomega.5c00549","volume":"10","author":"FJN Ferreira","year":"2025","unstructured":"Ferreira FJN, Carneiro AS (2025) AI-driven drug discovery: a comprehensive review. ACS Omega 10:23889\u201323903","journal-title":"ACS Omega"},{"key":"515_CR52","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrmicro3138","volume":"11","author":"EL Flannery","year":"2013","unstructured":"Flannery EL, Chatterjee AK, Winzeler EA (2013) Antimalarial drug discovery - approaches and progress towards new medicines. Nat Rev Microbiol 11:849\u2013862","journal-title":"Nat Rev Microbiol"},{"key":"515_CR53","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","volume":"7","author":"B Forte","year":"2021","unstructured":"Forte B, Ottilie S, Plater A, Campo B, Dechering KJ, Gamo FJ, Goldberg DE, Istvan ES, Lee M, Lukens AK et al (2021a) Prioritization of molecular targets for antimalarial drug discovery. ACS Infect Dis 7:2764\u20132776","journal-title":"ACS Infect Dis"},{"key":"515_CR54","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1021\/acsinfecdis.1c00322","volume":"7","author":"B Forte","year":"2021","unstructured":"Forte B, Ottilie S, Plater A, Campo B, Dechering KJ, Gamo FJ, Goldberg DE, Istvan ES, Lee M, Lukens AK et al (2021b) Prioritization of molecular targets for antimalarial drug discovery. ACS Infect Dis 7:2764\u20132776","journal-title":"ACS Infect Dis"},{"key":"515_CR55","doi-asserted-by":"crossref","unstructured":"Francis SE, Sullivan DJ Jr., Goldberg DE (1997) Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu Rev Microbiol 51:97\u2013123","DOI":"10.1146\/annurev.micro.51.1.97"},{"key":"515_CR56","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.pt.2004.07.007","volume":"20","author":"U Frevert","year":"2004","unstructured":"Frevert U (2004) Sneaking in through the back entrance: the biology of malaria liver stages. Trends Parasitol 20:417\u2013424","journal-title":"Trends Parasitol"},{"key":"515_CR57","doi-asserted-by":"publisher","first-page":"10757","DOI":"10.1021\/acs.jmedchem.4c02799","volume":"68","author":"S Gachuhi","year":"2025","unstructured":"Gachuhi S, Kamunya S, Fienberg S, Wambua L, Salomane N, Mayoka G, Taylor D, Coertzen D, van der Watt M, Reader J et al (2025) Medicinal chemistry progression of sapanisertib, the anticancer and dual Plasmodium phosphatidylinositol 4-kinase beta and cGMP-dependent protein kinase inhibitor, for malaria. J Med Chem 68:10757\u201310770","journal-title":"J Med Chem"},{"key":"515_CR58","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nature09107","volume":"465","author":"FJ Gamo","year":"2010","unstructured":"Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S et al (2010) Thousands of chemical starting points for antimalarial lead identification. Nature 465:305\u2013310","journal-title":"Nature"},{"key":"515_CR59","doi-asserted-by":"publisher","first-page":"E3012","DOI":"10.1073\/pnas.1520693113","volume":"113","author":"\u00c9 Gazanion","year":"2016","unstructured":"Gazanion \u00c9, Fern\u00e1ndez-Prada C, Papadopoulou B, Leprohon P, Ouellette M (2016) Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania. Proc Natl Acad Sci USA 113:E3012\u2013E3021","journal-title":"Proc Natl Acad Sci USA"},{"key":"515_CR60","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1007\/s11030-023-10770-z","volume":"28","author":"P Godara","year":"2024","unstructured":"Godara P, Reddy KS, Sahu W, Naik B, Srivastava V, Das R, Mahor A, Kumar P, Giri R, Anirudh J et al (2024) Structure-based virtual screening against multiple Plasmodium falciparum kinases reveals antimalarial compounds. Mol Divers 28:3661\u20133681","journal-title":"Mol Divers"},{"key":"515_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s44386-025-00006-5","volume":"2","author":"KP Godinez-Macias","year":"2025","unstructured":"Godinez-Macias KP, Chen D, Wallis JL, Siegel MG, Adam A, Bopp S, Carolino K, Coulson LB, Durst G, Thathy V et al (2025a) Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining. npj Drug Discov 2:3","journal-title":"npj Drug Discov"},{"key":"515_CR62","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s44386-025-00006-5","volume":"2","author":"KP Godinez-Macias","year":"2025","unstructured":"Godinez-Macias KP, Chen D, Wallis JL, Siegel MG, Adam A, Bopp S, Carolino K, Coulson LB, Durst G, Thathy V et al (2025b) Revisiting the Plasmodium falciparum druggable genome using predicted structures and data mining. NPJ Drug Discov 2:3","journal-title":"NPJ Drug Discov"},{"key":"515_CR63","doi-asserted-by":"publisher","first-page":"a008524","DOI":"10.1101\/cshperspect.a008524","volume":"6","author":"F Gomez","year":"2014","unstructured":"Gomez F, Hirbo J, Tishkoff SA (2014) Genetic variation and adaptation in Africa: implications for human evolution and disease. Cold Spring Harb Perspect Biol 6:a008524","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"515_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03888-8","volume":"20","author":"B Greenwood","year":"2021","unstructured":"Greenwood B, Cairns M, Chaponda M, Chico RM, Dicko A, Ouedraogo JB, Phiri KS, Ter Kuile FO, Chandramohan D (2021) Combining malaria vaccination with chemoprevention: a promising new approach to malaria control. Malar J 20:361","journal-title":"Malar J"},{"key":"515_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2022.102220","volume":"70","author":"F Guerra","year":"2022","unstructured":"Guerra F, Winzeler EA (2022) New targets for antimalarial drug discovery. Curr Opin Microbiol 70:102220","journal-title":"Curr Opin Microbiol"},{"key":"515_CR66","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/nature09099","volume":"465","author":"WA Guiguemde","year":"2010","unstructured":"Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F et al (2010) Chemical genetics of Plasmodium falciparum. Nature 465:311\u2013315","journal-title":"Nature"},{"key":"515_CR67","doi-asserted-by":"publisher","unstructured":"Gupta AK, Eliasen AM, Andahazy W, Zhou F, Henson K, Chi V, Woods AK, Joseph SB, Kuhen KL, Wisler J et al (2024) A prodrug strategy to reposition atovaquone et as a long-acting injectable for malaria chemoprotection. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.02.08.579395","DOI":"10.1101\/2024.02.08.579395"},{"key":"515_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05914-0","volume":"15","author":"SV Ha","year":"2025","unstructured":"Ha SV, Jaensch S, Ka\u0144du\u0142a MM, Herman D, Czodrowski P, Ceulemans H (2025) Cross modality learning of cell painting and transcriptomics data improves mechanism of action clustering and bioactivity modelling. Sci Rep 15:23010","journal-title":"Sci Rep"},{"key":"515_CR69","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1080\/14622416.2024.2428587","volume":"25","author":"SB Haga","year":"2024","unstructured":"Haga SB (2024) Artificial intelligence, medications, pharmacogenomics, and ethics. Pharmacogenomics 25:611\u2013622","journal-title":"Pharmacogenomics"},{"key":"515_CR70","doi-asserted-by":"publisher","first-page":"54","DOI":"10.7861\/clinmedicine.14-1-54","volume":"14","author":"J Hanefeld","year":"2014","unstructured":"Hanefeld J (2014) The global fund to fight AIDS, tuberculosis and malaria: 10 years on. Clin Med 14:54\u201357","journal-title":"Clin Med"},{"key":"515_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2728-8","volume":"18","author":"R Hooft van Huijsduijnen","year":"2019","unstructured":"Hooft van Huijsduijnen R, Wells T, Tanner M, Wittlin S (2019) Two successful decades of Swiss collaborations to develop new anti-malarials. Malar J 18:94","journal-title":"Malar J"},{"key":"515_CR72","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.pt.2016.04.014","volume":"32","author":"ML Hovlid","year":"2016","unstructured":"Hovlid ML, Winzeler EA (2016) Phenotypic screens in antimalarial drug discovery. Trends Parasitol 32:697\u2013707","journal-title":"Trends Parasitol"},{"key":"515_CR73","doi-asserted-by":"publisher","unstructured":"Ishii R, Sakura T, Hong J, Yasuo K, Hattori K, Willis PA, Kato T, Inaoka DK (2025) Efficient identification of antimalarials with novel mechanism of action via multi-sample transcriptomic profiling. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.02.27.640686","DOI":"10.1101\/2025.02.27.640686"},{"key":"515_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3897\/pharmacia.71.e129020","volume":"71","author":"A Ivanov","year":"2024","unstructured":"Ivanov A, Getova-Kolarova V, Getov I (2024) Research and analysis of regulatory framework and harmonisation of repurposing. Pharmacia 71:1\u20137","journal-title":"Pharmacia"},{"key":"515_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104009","volume":"29","author":"MKP Jayatunga","year":"2024","unstructured":"Jayatunga MKP, Ayers M, Bruens L, Jayanth D, Meier C (2024) How successful are AI-discovered drugs in clinical trials? A first analysis and emerging lessons. Drug Discov Today 29:104009","journal-title":"Drug Discov Today"},{"key":"515_CR76","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1021\/acs.jcim.3c01619","volume":"64","author":"P Kamya","year":"2024","unstructured":"Kamya P, Ozerov IV, Pun FW, Tretina K, Fokina T, Chen S, Naumov V, Long X, Lin S, Korzinkin M et al (2024) PandaOmics: an AI-driven platform for therapeutic target and biomarker discovery. J Chem Inf Model 64:3961\u20133969","journal-title":"J Chem Inf Model"},{"key":"515_CR77","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/s41564-026-02410-7","volume":"11","author":"M Kanai","year":"2026","unstructured":"Kanai M, Mok S, Yeo T, Shears MJ, Jeon JH, Narwal SK, Ross LS, Wiradiputri K, Haile MT, Tripathi AK et al (2026) Identification of genetic markers of quinine partial resistance in Plasmodium falciparum. Nat Microbiol 11:2213\u20132231","journal-title":"Nat Microbiol"},{"key":"515_CR78","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00805-24","volume":"15","author":"J Kane","year":"2024","unstructured":"Kane J, Li X, Kumar S, Button-Simons KA, Vendrely Brenneman KM, Dahlhoff H, Sievert MAC, Checkley LA, Shoue DA, Singh PP et al (2024) A Plasmodium falciparum genetic cross reveals the contributions of pfcrt and plasmepsin II\/III to piperaquine drug resistance. mBio 15:e0080524","journal-title":"mBio"},{"key":"515_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2024.106795","volume":"198","author":"D Karunakaran","year":"2024","unstructured":"Karunakaran D, Mutyam SK, Fu M, Chen J, Pham KHN, Pou S, Winter RW, Nilsen A, Dodean RA, Smilkstein MJ et al (2024) Long-acting intramuscular injections of ELQ-331, an antimalarial agent. Eur J Pharm Sci 198:106795","journal-title":"Eur J Pharm Sci"},{"key":"515_CR80","doi-asserted-by":"publisher","first-page":"e0164895","DOI":"10.1371\/journal.pone.0164895","volume":"11","author":"KR Kesely","year":"2016","unstructured":"Kesely KR, Pantaleo A, Turrini FM, Olupot-Olupot P, Low PS (2016) Inhibition of an erythrocyte tyrosine kinase with imatinib prevents Plasmodium falciparum egress and terminates parasitemia. PLoS ONE 11:e0164895","journal-title":"PLoS ONE"},{"key":"515_CR81","doi-asserted-by":"publisher","first-page":"6683","DOI":"10.1016\/j.vaccine.2014.06.033","volume":"32","author":"KE Kester","year":"2014","unstructured":"Kester KE, Gray Heppner D, Moris P, Ofori-Anyinam O, Krzych U, Tornieporth N, McKinney D, Delchambre M, Ockenhouse CF, Voss G et al (2014) Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 adjuvant system in healthy, malaria na\u00efve adults. Vaccine 32:6683\u20136691","journal-title":"Vaccine"},{"key":"515_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1247-0","volume":"15","author":"S Khan","year":"2016","unstructured":"Khan S (2016) Recent advances in the biology and drug targeting of malaria parasite aminoacyl-tRNA synthetases. Malar J 15:203","journal-title":"Malar J"},{"key":"515_CR83","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1074-5521(00)00124-1","volume":"7","author":"M Knockaert","year":"2000","unstructured":"Knockaert M, Gray N, Damiens E, Chang YT, Grellier P, Grant K, Fergusson D, Mottram J, Soete M, Dubremetz JF et al (2000) Intracellular targets of cyclin-dependent kinase inhibitors: identification by affinity chromatography using immobilised inhibitors. Chem Biol 7:411\u2013422","journal-title":"Chem Biol"},{"key":"515_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08272-z","volume":"22","author":"N Krishnamurthy","year":"2022","unstructured":"Krishnamurthy N, Grimshaw AA, Axson SA, Choe SH, Miller JE (2022) Drug repurposing: a systematic review on root causes, barriers and facilitators. BMC Health Serv Res 22:970","journal-title":"BMC Health Serv Res"},{"key":"515_CR85","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202518493","volume":"64","author":"H Langeveld","year":"2025","unstructured":"Langeveld H, Maepa K, Maree M, Thibaud JL, Salomane N, Bridgwater R, Famodimu MT, Godoy LC, Pasaje CFA, Boonyalai N et al (2025) Targeting aurora kinases as essential cell-cycle regulators to deliver multi-stage antimalarials against Plasmodium Falciparum. Angew Chem Int Ed Engl 64:e202518493","journal-title":"Angew Chem Int Ed Engl"},{"key":"515_CR86","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1093\/bfgp\/elz012","volume":"18","author":"MCS Lee","year":"2019","unstructured":"Lee MCS, Lindner SE, Lopez-Rubio JJ, Llinas M (2019) Cutting back malaria: CRISPR\/Cas9 genome editing of Plasmodium. Brief Funct Genom 18:281\u2013289","journal-title":"Brief Funct Genom"},{"key":"515_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-47765-3","volume":"16","author":"H Leung","year":"2026","unstructured":"Leung H, Duan C, Gou W, Chen J, Xin Y, Zheng Z, Naumov V, Gennert D, Zhang M, Aliper A et al (2026) Advancing target discovery through disease-specific integration of multi-modal target identification models and comprehensive benchmarking system. Sci Rep 16:17018","journal-title":"Sci Rep"},{"key":"515_CR88","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13321-024-00812-5","volume":"16","author":"HH Loeffler","year":"2024","unstructured":"Loeffler HH, He J, Tibo A, Janet JP, Voronov A, Mervin LH, Engkvist O (2024) Reinvent 4: modern AI-driven generative molecule design. J Cheminform 16:20","journal-title":"J Cheminform"},{"key":"515_CR89","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1002\/cbic.202100155","volume":"22","author":"K-Y Lu","year":"2021","unstructured":"Lu K-Y, Mansfield CR, Fitzgerald MC, Derbyshire ER (2021a) Chemoproteomics for Plasmodium parasite drug target discovery. ChemBioChem 22:2591\u20132599","journal-title":"ChemBioChem"},{"key":"515_CR90","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1002\/cbic.202100155","volume":"22","author":"KY Lu","year":"2021","unstructured":"Lu KY, Mansfield CR, Fitzgerald MC, Derbyshire ER (2021b) Chemoproteomics for Plasmodium parasite drug target discovery. Chembiochem 22:2591\u20132599","journal-title":"Chembiochem"},{"key":"515_CR91","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1128\/AAC.01949-15","volume":"60","author":"L Lucantoni","year":"2016","unstructured":"Lucantoni L, Fidock DavidA, Avery VickyM (2016) Luciferase-based, high-throughput assay for screening and profiling transmission-blocking compounds against Plasmodium falciparum gametocytes. Antimicrob Agents Chemother 60:2097\u20132107","journal-title":"Antimicrob Agents Chemother"},{"key":"515_CR92","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk9893","volume":"386","author":"MR Luth","year":"2024","unstructured":"Luth MR, Godinez-Macias KP, Chen D, Okombo J, Thathy V, Cheng X, Daggupati S, Davies H, Dhingra SK, Economy JM et al (2024) Systematic in vitro evolution in Plasmodium falciparum reveals key determinants of drug resistance. Science 386:eadk9893","journal-title":"Science"},{"key":"515_CR93","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1021\/acsinfecdis.7b00276","volume":"4","author":"MR Luth","year":"2018","unstructured":"Luth MR, Gupta P, Ottilie S, Winzeler EA (2018) Using in vitro evolution and whole genome analysis to discover next generation targets for antimalarial drug discovery. ACS Infect Dis 4:301\u2013314","journal-title":"ACS Infect Dis"},{"key":"515_CR94","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2549-1","volume":"17","author":"F Macintyre","year":"2018","unstructured":"Macintyre F, Ramachandruni H, Burrows JN, Holm R, Thomas A, M\u00f6hrle JJ, Duparc S, Hooft van Huijsduijnen R, Greenwood B, Gutteridge WE et al (2018) Injectable anti-malarials revisited: discovery and development of new agents to protect against malaria. Malar J 17:402","journal-title":"Malar J"},{"key":"515_CR95","doi-asserted-by":"publisher","first-page":"RP98221","DOI":"10.7554\/eLife.98221","volume":"13","author":"SP Maher","year":"2025","unstructured":"Maher SP, Bakowski MA, Vantaux A, Flannery EL, Andolina C, Gupta M, Antonova-Koch Y, Argomaniz M, Cabrera-Mora M, Campo B et al (2025) A drug repurposing approach reveals targetable epigenetic pathways in Plasmodium vivax hypnozoites. eLife 13:RP98221","journal-title":"eLife"},{"key":"515_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-99152-9","volume":"11","author":"SP Maher","year":"2021","unstructured":"Maher SP, Vantaux A, Chaumeau V, Chua ACY, Cooper CA, Andolina C, P\u00e9neau J, Rouillier M, Rizopoulos Z, Phal S et al (2021a) Probing the distinct chemosensitivity of Plasmodium vivax liver stage parasites and demonstration of 8-aminoquinoline radical cure activity in vitro. Sci Rep 11:19905","journal-title":"Sci Rep"},{"key":"515_CR97","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.4253","volume":"11","author":"SP Maher","year":"2021","unstructured":"Maher SP, Vantaux A, Cooper CA, Chasen NM, Cheng WT, Joyner CJ, Manetsch R, Witkowski B, Kyle D (2021b) A phenotypic screen for the liver stages of Plasmodium vivax. Bio Protoc 11:e4253","journal-title":"Bio Protoc"},{"key":"515_CR98","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.25903","volume":"6","author":"G Manzoni","year":"2017","unstructured":"Manzoni G, Marinach C, Top\u00e7u S, Briquet S, Grand M, Tolle M, Gransagne M, Lescar J, Andolina C, Franetich J-F et al (2017) Plasmodium P36 determines host cell receptor usage during sporozoite invasion. eLife 6:e25903","journal-title":"eLife"},{"key":"515_CR99","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2174\/187152610791163336","volume":"10","author":"AP Margaret","year":"2010","unstructured":"Margaret AP, Pradipsinh KR (2010) Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy. Infect Disord Drug Targets 10:226\u2013239","journal-title":"Infect Disord Drug Targets"},{"key":"515_CR100","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nature12782","volume":"504","author":"CW McNamara","year":"2013","unstructured":"McNamara CW, Lee MC, Lim CS, Lim SH, Roland J, Simon O, Yeung BK, Chatterjee AK, McCormack SL, Manary MJ et al (2013) Targeting Plasmodium PI(4)K to eliminate malaria. Nature 504:248\u2013253","journal-title":"Nature"},{"key":"515_CR101","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1128\/AAC.04684-14","volume":"59","author":"C Miguel-Blanco","year":"2015","unstructured":"Miguel-Blanco C, Leli\u00e8vre J, Delves Michael J, Bardera Ana I, Presa Jes\u00fas L, L\u00f3pez-Barrag\u00e1n Mar\u00eda J, Ruecker A, Marques S, Sinden Robert E, Herreros E (2015) Imaging-based high-throughput screening assay to identify new molecules with transmission-blocking potential against Plasmodium falciparum female gamete formation. Antimicrob Agents Chemother 59:3298\u20133305","journal-title":"Antimicrob Agents Chemother"},{"key":"515_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-51201-3","volume":"15","author":"M Mohammed","year":"2024","unstructured":"Mohammed M, Dziedziech A, Macedo D, Huppertz F, Veith Y, Postel Z, Christ E, Scheytt R, Slotte T, Henriksson J et al (2024) Single-cell transcriptomics reveal transcriptional programs underlying male and female cell fate during Plasmodium falciparum gametocytogenesis. Nat Commun 15:7177","journal-title":"Nat Commun"},{"key":"515_CR103","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4269\/ajtmh.22-0567","volume":"108","author":"R Mohammed","year":"2023","unstructured":"Mohammed R, Asres MS, Gudina EK, Adissu W, Johnstone H, Marrast AC, Donini C, Duparc S, Yilma D (2023) Efficacy, safety, tolerability, and pharmacokinetics of MMV390048 in acute uncomplicated malaria. Am J Trop Med Hyg 108:81\u201384","journal-title":"Am J Trop Med Hyg"},{"key":"515_CR104","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1093\/eurjcn\/zvaf066","volume":"24","author":"P Moons","year":"2025","unstructured":"Moons P, Dou B, Desmedt CP (2025) Google\u2019s AI co-scientist and OpenAI\u2019s deep research: new partners in health research? Eur J Cardiovasc Nurs 24:800\u2013807","journal-title":"Eur J Cardiovasc Nurs"},{"key":"515_CR105","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1021\/acs.molpharmaceut.4c01086","volume":"22","author":"JA Napoli","year":"2025","unstructured":"Napoli JA, Reutlinger M, Brandl P, Wang W, Hert J, Desai P (2025) Multitask deep learning models of combined industrial absorption, distribution, metabolism, and excretion datasets to improve generalization. Mol Pharm 22:1892\u20131900","journal-title":"Mol Pharm"},{"key":"515_CR106","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/s41587-025-02752-3","volume":"43","author":"B Nasto","year":"2025","unstructured":"Nasto B (2025) Non-profits wade in where for-profit life science investment fears to tread. Nat Biotechnol 43:1221\u20131226","journal-title":"Nat Biotechnol"},{"key":"515_CR107","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-4939-9550-9_9","volume":"2013","author":"CL Ng","year":"2019","unstructured":"Ng CL, Fidock DA (2019) Plasmodium falciparum in vitro drug resistance selections and gene editing. Methods Mol Biol 2013:123\u2013140","journal-title":"Methods Mol Biol"},{"key":"515_CR108","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.pt.2017.05.009","volume":"33","author":"CL Ng","year":"2017","unstructured":"Ng CL, Fidock DA, Bogyo M (2017) Protein degradation systems as antimalarial therapeutic targets. Trends Parasitol 33:731\u2013743","journal-title":"Trends Parasitol"},{"key":"515_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-05155-y","volume":"23","author":"G-B Nguyen","year":"2024","unstructured":"Nguyen G-B, Cooper CA, McWhorter O, Sharma R, Elliot A, Ruberto A, Freitas R, Pathak AK, Kyle DE, Maher SP (2024) Screening the global health priority box against Plasmodium berghei liver stage parasites using an inexpensive luciferase detection protocol. Malar J 23:357","journal-title":"Malar J"},{"key":"515_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39914-3","volume":"14","author":"TD Nguyen","year":"2023","unstructured":"Nguyen TD, Gao B, Amaratunga C, Dhorda M, Tran TN-A, White NJ, Dondorp AM, Boni MF, Aguas R (2023) Preventing antimalarial drug resistance with triple artemisinin-based combination therapies. Nat Commun 14:4568","journal-title":"Nat Commun"},{"key":"515_CR111","doi-asserted-by":"publisher","unstructured":"Odah M (2025) Artificial intelligence meets drug discovery: a systematic review on AI-powered target identification and molecular design. https:\/\/doi.org\/10.20944\/preprints202503.0912.v1","DOI":"10.20944\/preprints202503.0912.v1"},{"key":"515_CR112","doi-asserted-by":"crossref","unstructured":"Okeke CJ, Ksouri A (2026) The role of precision medicine in malaria: an innovative treatment approach. In: Radouani F, Zass L, Fadlelmola FM (eds) Precision medicine in Africa: promises and opportunities. Springer Nature Singapore, pp 145\u2013160","DOI":"10.1007\/978-981-96-8959-0_9"},{"key":"515_CR113","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.pt.2021.02.007","volume":"37","author":"J Okombo","year":"2021","unstructured":"Okombo J, Kanai M, Deni I, Fidock DA (2021) Genomic and genetic approaches to studying antimalarial drug resistance and Plasmodium Biology. Trends Parasitol 37:476\u2013492","journal-title":"Trends Parasitol"},{"key":"515_CR114","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.3390\/microorganisms11081966","volume":"11","author":"DT Ouologuem","year":"2023","unstructured":"Ouologuem DT, Dara A, Kone A, Ouattara A, Djimde AA (2023) Plasmodium falciparum development from gametocyte to oocyst: insight from functional studies. Microorganisms 11:1966","journal-title":"Microorganisms"},{"key":"515_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04966-3","volume":"9","author":"HJ Painter","year":"2018","unstructured":"Painter HJ, Chung NC, Sebastian A, Albert I, Storey JD, Llinas M (2018) Genome-wide real-time in vivo transcriptional dynamics during Plasmodium falciparum blood-stage development. Nat Commun 9:2656","journal-title":"Nat Commun"},{"key":"515_CR116","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s42003-022-03510-w","volume":"5","author":"G Paonessa","year":"2022","unstructured":"Paonessa G, Siciliano G, Graziani R, Lalli C, Cecchetti O, Alli C, La Valle R, Petrocchi A, Sferrazza A, Bisbocci M et al (2022) Gametocyte-specific and all-blood-stage transmission-blocking chemotypes discovered from high throughput screening on Plasmodium falciparum gametocytes. Commun Biol 5:547","journal-title":"Commun Biol"},{"key":"515_CR117","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aad9735","volume":"9","author":"T Paquet","year":"2017","unstructured":"Paquet T, Le Manach C, Cabrera DG, Younis Y, Henrich PP, Abraham TS, Lee MCS, Basak R, Ghidelli-Disse S, Lafuente-Monasterio MJ et al (2017a) Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. Sci Transl Med 9:eaad9735","journal-title":"Sci Transl Med"},{"key":"515_CR118","doi-asserted-by":"publisher","first-page":"eaad9735","DOI":"10.1126\/scitranslmed.aad9735","volume":"9","author":"T Paquet","year":"2017","unstructured":"Paquet T, Le Manach C, Cabrera DG, Younis Y, Henrich PP, Abraham TS, Lee MCS, Basak R, Ghidelli-Disse S, Lafuente-Monasterio MJ et al (2017b) Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase. Sci Transl Med 9:eaad9735","journal-title":"Sci Transl Med"},{"key":"515_CR119","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1021\/acs.jcim.5b00680","volume":"56","author":"E Pavadai","year":"2016","unstructured":"Pavadai E, El Mazouni F, Wittlin S, de Kock C, Phillips MA, Chibale K (2016) Identification of new human malaria parasite Plasmodium falciparum dihydroorotate dehydrogenase inhibitors by pharmacophore and structure-based virtual screening. J Chem Inf Model 56:548\u2013562","journal-title":"J Chem Inf Model"},{"key":"515_CR120","doi-asserted-by":"publisher","unstructured":"Pazicky S, Dziekan JM, Tjia S, Bopp S, Wirth D, Bozdech Z (2026) Thermal proteome profiling identifies new drug targets in Plasmodium falciparum parasites. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.01.30.702724","DOI":"10.64898\/2026.01.30.702724"},{"key":"515_CR121","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-42801-x","volume":"9","author":"M Penzo","year":"2019","unstructured":"Penzo M, de las Heras-Due\u00f1a L, Mata-Cantero L, Diaz-Hernandez B, Vazquez-Mu\u00f1iz M-J, Ghidelli-Disse S, Drewes G, Fernandez-Alvaro E, Baker DA (2019) High-throughput screening of the Plasmodium falciparum cGMP-dependent protein kinase identified a thiazole scaffold which kills erythrocytic and sexual stage parasites. Sci Rep 9:7005","journal-title":"Sci Rep"},{"key":"515_CR122","doi-asserted-by":"publisher","first-page":"296ra111","DOI":"10.1126\/scitranslmed.aaa6645","volume":"7","author":"MA Phillips","year":"2015","unstructured":"Phillips MA, Lotharius J, Marsh K, White J, Dayan A, White KL, Njoroge JW, El Mazouni F, Lao Y, Kokkonda S et al (2015) A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. Sci Transl Med 7:296ra111\u2013296ra111","journal-title":"Sci Transl Med"},{"key":"515_CR123","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.chom.2015.12.001","volume":"19","author":"M Plouffe David","year":"2016","unstructured":"Plouffe David M, Wree M, Du Alan Y, Meister S, Li F, Patra K, Lubar A, Okitsu Shinji L, Flannery Erika L, Kato N et al (2016) High-throughput assay and discovery of small molecules that interrupt malaria transmission. Cell Host Microbe 19:114\u2013126","journal-title":"Cell Host Microbe"},{"key":"515_CR124","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04115-8","volume":"21","author":"CV Plowe","year":"2022","unstructured":"Plowe CV (2022) Malaria chemoprevention and drug resistance: a review of the literature and policy implications. Malar J 21:104","journal-title":"Malar J"},{"key":"515_CR125","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41586-025-09039-2","volume":"643","author":"AS Probst","year":"2025","unstructured":"Probst AS, Paton DG, Appetecchia F, Bopp S, Adams KL, Rinvee TA, Pou S, Winter R, Du EW, Yahiya S et al (2025) In vivo screen of Plasmodium targets for mosquito-based malaria control. Nature 643:785\u2013793","journal-title":"Nature"},{"key":"515_CR126","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.tips.2023.06.010","volume":"44","author":"FW Pun","year":"2023","unstructured":"Pun FW, Ozerov IV, Zhavoronkov A (2023) AI-powered therapeutic target discovery. Trends Pharm Sci 44:561\u2013572","journal-title":"Trends Pharm Sci"},{"key":"515_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2025.104390","volume":"30","author":"A Recino","year":"2025","unstructured":"Recino A, Rayner MLD, Rohn JL, Della Pasqua O, Recino A, Rayner MLD, Rohn JL, Carter B, Cupani A, Dahlmann-Noor A et al (2025) Therapeutic innovation in drug repurposing: challenges and opportunities. Drug Discov Today 30:104390","journal-title":"Drug Discov Today"},{"key":"515_CR128","doi-asserted-by":"publisher","unstructured":"Redhi D, Mulubwa M, Mmonwa MM, Njoroge M, Krugmann L, Chibale K (2026) Repurposing drugs for malaria through a human dose prediction: a case study with berzosertib. Clin Pharmacol Ther. https:\/\/doi.org\/10.1002\/cpt.70303","DOI":"10.1002\/cpt.70303"},{"key":"515_CR129","doi-asserted-by":"publisher","first-page":"102cm129","DOI":"10.1126\/scitranslmed.3002939","volume":"3","author":"MA Rogawski","year":"2011","unstructured":"Rogawski MA, Federoff HJ (2011) Disclosure of clinical trial results when product development is abandoned. Sci Transl Med 3:102cm129\u2013102cm129","journal-title":"Sci Transl Med"},{"key":"515_CR130","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04221-9","volume":"9","author":"A Roth","year":"2018","unstructured":"Roth A, Maher SP, Conway AJ, Ubalee R, Chaumeau V, Andolina C, Kaba SA, Vantaux A, Bakowski MA, Thomson-Luque R et al (2018) A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum. Nat Commun 9:1837","journal-title":"Nat Commun"},{"key":"515_CR131","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.pt.2024.10.017","volume":"40","author":"M Singer","year":"2024","unstructured":"Singer M, Kanatani S, Castillo SG, Frischknecht F, Sinnis P (2024) The Plasmodium circumsporozoite protein. Trends Parasitol 40:1124\u20131134","journal-title":"Trends Parasitol"},{"key":"515_CR132","doi-asserted-by":"publisher","first-page":"5886","DOI":"10.1021\/acs.jmedchem.1c02134","volume":"65","author":"J Singh","year":"2022","unstructured":"Singh J (2022) The ascension of targeted covalent inhibitors. J Med Chem 65:5886\u20135901","journal-title":"J Med Chem"},{"key":"515_CR133","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/nrd3410","volume":"10","author":"J Singh","year":"2011","unstructured":"Singh J, Petter RC, Baillie TA, Whitty A (2011) The resurgence of covalent drugs. Nat Rev Drug Discov 10:307\u2013317","journal-title":"Nat Rev Drug Discov"},{"key":"515_CR134","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41573-023-00772-9","volume":"22","author":"JL Siqueira-Neto","year":"2023","unstructured":"Siqueira-Neto JL, Wicht KJ, Chibale K, Burrows JN, Fidock DA, Winzeler EA (2023) Antimalarial drug discovery: progress and approaches. Nat Rev Drug Discov 22:807\u2013826","journal-title":"Nat Rev Drug Discov"},{"key":"515_CR135","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1038\/s41591-025-03739-y","volume":"31","author":"J Skinner","year":"2025","unstructured":"Skinner J, Kayentao K, Ongoiba A, Healy SA, Hu Z, Preston AC, Niangaly A, Schwabl P, Cisse H, Doumbo S et al (2025) Anti-sporozoite monoclonal antibody for malaria prevention: secondary efficacy outcome of a phase 2 randomized trial. Nat Med 31:2682\u20132690","journal-title":"Nat Med"},{"key":"515_CR136","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2921-9","volume":"18","author":"MJ Smilkstein","year":"2019","unstructured":"Smilkstein MJ, Pou S, Krollenbrock A, Bleyle LA, Dodean RA, Frueh L, Hinrichs DJ, Li Y, Martinson T, Munar MY et al (2019) ELQ-331 as a prototype for extremely durable chemoprotection against malaria. Malar J 18:291","journal-title":"Malar J"},{"key":"515_CR137","doi-asserted-by":"publisher","first-page":"e62906","DOI":"10.1371\/journal.pone.0062906","volume":"8","author":"T Spangenberg","year":"2013","unstructured":"Spangenberg T, Burrows JN, Kowalczyk P, McDonald S, Wells TNC, Willis P (2013) The open access malaria box: a drug discovery catalyst for neglected diseases. PLoS ONE 8:e62906","journal-title":"PLoS ONE"},{"key":"515_CR138","doi-asserted-by":"publisher","first-page":"e1007722","DOI":"10.1371\/journal.ppat.1007722","volume":"15","author":"BH Stokes","year":"2019","unstructured":"Stokes BH, Yoo E, Murithi JM, Luth MR, Afanasyev P, da Fonseca PCA, Winzeler EA, Ng CL, Bogyo M, Fidock DA (2019a) Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents. PLoS Pathog 15:e1007722","journal-title":"PLoS Pathog"},{"key":"515_CR139","doi-asserted-by":"publisher","first-page":"e1007722","DOI":"10.1371\/journal.ppat.1007722","volume":"15","author":"BH Stokes","year":"2019","unstructured":"Stokes BH, Yoo E, Murithi JM, Luth MR, Afanasyev P, da Fonseca PCA, Winzeler EA, Ng CL, Bogyo M, Fidock DA (2019b) Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents. PLoS Pathog 15:e1007722","journal-title":"PLoS Pathog"},{"key":"515_CR140","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.pt.2018.08.003","volume":"34","author":"KE Swearingen","year":"2018","unstructured":"Swearingen KE, Lindner SE (2018) Plasmodium parasites viewed through proteomics. Trends Parasitol 34:945\u2013960","journal-title":"Trends Parasitol"},{"key":"515_CR141","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/clpt.2012.236","volume":"93","author":"DC Swinney","year":"2013","unstructured":"Swinney DC (2013) Phenotypic vs. target-based drug discovery for first-in-class medicines. Clin Pharm Ther 93:299\u2013301","journal-title":"Clin Pharm Ther"},{"key":"515_CR142","doi-asserted-by":"publisher","first-page":"359","DOI":"10.4269\/ajtmh.19-0706","volume":"103","author":"J Takata","year":"2020","unstructured":"Takata J, Sondo P, Humphreys GS, Burrow R, Maguire B, Hossain MS, Das D, Commons RJ, Price RN, Guerin PJ (2020) The worldwide antimalarial resistance network clinical trials publication library: a live, open-access database of Plasmodium treatment efficacy trials. Am J Trop Med Hyg 103:359\u2013368","journal-title":"Am J Trop Med Hyg"},{"key":"515_CR143","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1021\/acs.accounts.5c00155","volume":"58","author":"Z Tu","year":"2025","unstructured":"Tu Z, Choure SJ, Fong MH, Roh J, Levin I, Yu K, Joung JF, Morgan N, Li SC, Sun X et al (2025) ASKCOS: open-source, data-driven synthesis planning. Acc Chem Res 58:1764\u20131775","journal-title":"Acc Chem Res"},{"key":"515_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41512-2","volume":"14","author":"G Turon","year":"2023","unstructured":"Turon G, Hlozek J, Woodland JG, Kumar A, Chibale K, Duran-Frigola M (2023) First fully-automated AI\/ML virtual screening cascade implemented at a drug discovery centre in Africa. Nat Commun 14:5736","journal-title":"Nat Commun"},{"key":"515_CR145","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64304-2","volume":"16","author":"G Turon","year":"2025","unstructured":"Turon G, Mulubwa M, Montaner A, Njoroge M, Chibale K, Duran-Frigola M (2025) Artificial intelligence coupled to pharmacometrics modelling to tailor malaria and tuberculosis treatment in Africa. Nat Commun 16:9258","journal-title":"Nat Commun"},{"key":"515_CR146","unstructured":"Turon G, Abel, L, Marina M-L, Arnau CC, Miquel D-F (2024) Ersilia model hub: a repository of AI\/ML for neglected tropical diseases. Zenodo"},{"key":"515_CR147","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","volume":"395","author":"RW van der Pluijm","year":"2020","unstructured":"van der Pluijm RW, Tripura R, Hoglund RM, Pyae Phyo A, Lek D, ul Islam A, Anvikar AR, Satpathi P, Satpathi S, Behera PK et al (2020) Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial. Lancet 395:1345\u20131360","journal-title":"Lancet"},{"key":"515_CR148","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nmeth.3432","volume":"12","author":"AM Vaughan","year":"2015","unstructured":"Vaughan AM, Pinapati RS, Cheeseman IH, Camargo N, Fishbaugher M, Checkley LA, Nair S, Hutyra CA, Nosten FH, Anderson TJ et al (2015) Plasmodium falciparum genetic crosses in a humanized mouse model. Nat Methods 12:631\u2013633","journal-title":"Nat Methods"},{"key":"515_CR149","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.pt.2020.07.009","volume":"36","author":"KM Vendrely","year":"2020","unstructured":"Vendrely KM, Kumar S, Li X, Vaughan AM (2020) Humanized mice and the rebirth of malaria genetic crosses. Trends Parasitol 36:850\u2013863","journal-title":"Trends Parasitol"},{"key":"515_CR150","unstructured":"Venture MFM (2025) MMV announces new partnership using AI-powered image analysis to accelerate malaria drug discovery"},{"key":"515_CR151","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01708-24","volume":"15","author":"RJ Wall","year":"2024","unstructured":"Wall RJ, MacGowan SA, Hallyburton I, Syed AJ, Ajay Castro S, Dey G, Milne R, Patterson S, Phelan J, Wiedemar N et al (2024) ResMAP-a saturation mutagenesis platform enabling parallel profiling of target-specific resistance-conferring mutations in Plasmodium. mBio 15:e0170824","journal-title":"mBio"},{"key":"515_CR152","doi-asserted-by":"crossref","unstructured":"Watson JA, Commons RJ, Tarning J, Simpson JA, Llanos Cuentas A, Lacerda MVG, Green JA, Koh G, Chu CS, Nosten FH et al (2022) The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: an individual patient data meta-analysis. Elife 11:e83433","DOI":"10.7554\/eLife.83433"},{"key":"515_CR153","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aea2531","volume":"17","author":"R Webster","year":"2025","unstructured":"Webster R, Oyong DA, Llewellyn S, Abd-Rahman AN, Potter AJ, Mukhiya R, Sahai N, Leelasena I, Ujvary E, Mathison S et al (2025) Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum. Sci Transl Med 17:eaea2531","journal-title":"Sci Transl Med"},{"key":"515_CR154","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/345253a0","volume":"345","author":"TE Wellems","year":"1990","unstructured":"Wellems TE, Panton LJ, Gluzman IY, do Rosario VE, Gwadz RW, Walker-Jonah A, Krogstad DJ (1990) Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345:253\u2013255","journal-title":"Nature"},{"key":"515_CR155","unstructured":"WHO (2025) World malaria report 2025. World Health Organization, Geneva"},{"key":"515_CR156","unstructured":"WHO (2023) WHO guidelines for malaria. World Health Organization, Gevena"},{"key":"515_CR157","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1146\/annurev-micro-020518-115546","volume":"74","author":"KJ Wicht","year":"2020","unstructured":"Wicht KJ, Mok S, Fidock DA (2020) Molecular mechanisms of drug resistance in Plasmodium falciparum malaria. Annu Rev Microbiol 74:431\u2013454","journal-title":"Annu Rev Microbiol"},{"key":"515_CR158","doi-asserted-by":"crossref","unstructured":"Wicht KJ, Woodland JG, Garnie LF, Langeveld H, Taylor D, Godoy LC, Pasaje CFA, de Souza ML, Siqueira-Neto JL, Ghidelli-Disse S et al (2025) The human Chk1 inhibitor CHIR-124 shows multistage activity against Plasmodium falciparum via dual inhibition of PfArk1 and hemozoin formation. ACS Chem Biol 21:1738\u20131748","DOI":"10.1021\/acschembio.6c00264"},{"key":"515_CR159","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.ijmm.2012.07.003","volume":"302","author":"CC Wirth","year":"2012","unstructured":"Wirth CC, Pradel G (2012) Molecular mechanisms of host cell egress by malaria parasites. Int J Med Microbiol 302:172\u2013178","journal-title":"Int J Med Microbiol"},{"key":"515_CR160","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112445","volume":"28","author":"C Wolff","year":"2025","unstructured":"Wolff C, Neuenschwander M, Beese CJ, Sitani D, Ramos MC, Srovnalova A, Varela MJ, Polishchuk P, Skopelitou KE, \u0160kuta C et al (2025) Morphological profiling data resource enables prediction of chemical compound properties. iScience 28:112445","journal-title":"iScience"},{"key":"515_CR161","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202425206","volume":"64","author":"JG Woodland","year":"2025","unstructured":"Woodland JG, Coertzen D, Wicht KJ, Hidalgo VF, Pasaje CFA, Godoy LC, Qahash T, Mmonwa MM, Dziwornu GA, Wambua L et al (2025) The ATM kinase inhibitor azd0156 is a potent inhibitor of Plasmodium phosphatidylinositol 4-Kinase (PI4Kbeta) and is an attractive candidate for medicinal chemistry optimization against malaria. Angew Chem Int Ed Engl 64:e202425206","journal-title":"Angew Chem Int Ed Engl"},{"key":"515_CR162","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","volume":"323","author":"OJ Wouters","year":"2020","unstructured":"Wouters OJ, McKee M, Luyten J (2020) Estimated research and development investment needed to bring a new medicine to market, 2009-2018. JAMA 323:844\u2013853","journal-title":"JAMA"},{"key":"515_CR163","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev-micro-032421-121210","volume":"77","author":"SC Xie","year":"2023","unstructured":"Xie SC, Griffin MDW, Winzeler EA, Ribas de Pouplana L, Tilley L (2023) Targeting aminoacyl tRNA Synthetases for Antimalarial Drug Development. Annu Rev Microbiol 77:111\u2013129","journal-title":"Annu Rev Microbiol"},{"key":"515_CR164","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.chembiol.2020.01.001","volume":"27","author":"E Yoo","year":"2020","unstructured":"Yoo E, Schulze CJ, Stokes BH, Onguka O, Yeo T, Mok S, Gnadig NF, Zhou Y, Kurita K, Foe IT et al (2020) The antimalarial natural product salinipostin A identifies essential alpha\/beta serine hydrolases involved in lipid metabolism in P. falciparum parasites. Cell Chem Biol 27:143\u2013157.e145","journal-title":"Cell Chem Biol"},{"key":"515_CR165","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1021\/jm3001373","volume":"55","author":"Y Younis","year":"2012","unstructured":"Younis Y, Douelle F, Feng T-S, Cabrera DG, Manach CL, Nchinda AT, Duffy S, White KL, Shackleford DM, Morizzi J et al (2012) 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential. J Med Chem 55:3479\u20133487","journal-title":"J Med Chem"},{"key":"515_CR166","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.3389\/fmicb.2020.626183","volume":"11","author":"X Yu","year":"2021","unstructured":"Yu X, Feng G, Zhang Q, Cao J (2021) From metabolite to metabolome: metabolomics applications in Plasmodium research. Front Microbiol 11:2020","journal-title":"Front Microbiol"},{"key":"515_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpdig.2025.100246","volume":"3","author":"M Zack","year":"2025","unstructured":"Zack M, Stupichev DN, Moore AJ, Slobodchikov ID, Sokolov DG, Trifonov IF, Gobbs A (2025) Artificial intelligence and multi-omics in pharmacogenomics: a new era of precision medicine. Mayo Clin Proc Digit Health 3:100246","journal-title":"Mayo Clin Proc Digit Health"},{"key":"515_CR168","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41591-024-03434-4","volume":"31","author":"K Zhang","year":"2025","unstructured":"Zhang K, Yang X, Wang Y, Yu Y, Huang N, Li G, Li X, Wu JC, Yang S (2025) Artificial intelligence in drug development. Nat Med 31:45\u201359","journal-title":"Nat Med"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00515-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00515-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:41:58Z","timestamp":1791819718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-026-00515-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":168,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00515-4","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"29 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}